Abdul Mannan: The Hardest Conversations in Myelofibrosis
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:
”Myelofibrosis is the hardest MPN to face.
For patients and for us.
Bone marrow replaced by scar tissue.
Spleen the size of a football. Fatigue that doesn’t lift.
And a prognosis that forces you into some of the most difficult conversations in haematology.
So when we risk-stratify, we have to get it right.
Here’s the simplest way to remember the molecular picture:
- CALR type 1 equal the one favourable signal in a tough disease. Better survival. The kindest mutation MF offers.
- ASXL1, SRSF2, EZH2, IDH1/2 equal high-risk mutations that drive faster progression and worse outcomes.
- U2AF1 Q157 equal now formally recognised as adverse in MIPSS70 plus v2.0 and GIPSS. A newer addition to an already difficult list.
- Getting this molecular profile right decides who needs transplant, and when.
MIPSS70 plus v2.0 (Guglielmelli et al., Journal of Clinical Oncology, 2018) and GIPSS (Passamonti et al., Leukemia, 2017) both integrate these mutations into risk scoring. These aren’t just academic exercises. They shape real decisions for real patients.
Memory line for trainees: CALR type 1 is kind. The rest are not.
In a disease this serious, clarity in risk assessment is the least we can offer our patients.
What’s the toughest MF conversation you’ve had with a patient recently?”

More posts from Abdul Mannan on Hemostasis Today.
-
Nov 21, 2026, 20:00Jeyda Star: The FAST Signs of Stroke and the Reality of Life Afterward
-
Nov 21, 2026, 19:59Daniel Lindholm: Women Showed the Largest Improvement in Stroke Risk Over Time in Heart Failure
-
Nov 21, 2026, 19:56Neil Arrowsmith: Raising Awareness of Pulmonary Embolism in Young People
-
Nov 21, 2026, 19:52Muhammad Zeeshan Jamal: Thrilled to Present Our Research on Intermediate-Risk Acute PE in Abu Dhabi
-
Nov 21, 2026, 19:50Mounisha Devireddy: Proud to Share Our Research on High-Risk PE in Pregnancy
-
Nov 21, 2026, 19:47Melissa Hollo: How Severe Anemia Increases the Odds of Acute HF During Pregnancy and Postpartum
-
Nov 21, 2026, 19:44Ashenafi Tazebew Amare: Building Sustainable Systems to Close the Anti-D Immunoglobulin Access Gap in LMICs
-
Nov 21, 2026, 19:43Sheharyar Raza: Interpreting Clotting Times Through Reptilase Time and Thrombin Time Assays
-
Nov 21, 2026, 19:42Minoo Ahmadinejad: Serving on the ISTH 2027 Scientific Theme Committee for Women’s Health